Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01234675 · ClinicalTrials.gov registry record · Phase 4
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
A Phase 4 study of Sleep and Fibromyalgia, sponsored by Mansoor Ahmed M.D..
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT01234675: Completed Phase 4 study of Sleep and Fibromyalgia, sponsored by Mansoor Ahmed M.D..
NCT01234675 is a Phase 4 study of Sleep and Fibromyalgia that has completed, run by Mansoor Ahmed M.D.. The registered enrollment target is 19 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01234675, a Phase 4 study of Sleep and Fibromyalgia, has completed, sponsored by Mansoor Ahmed M.D..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
Fibromyalgia is a condition of chronic widespread pain, sleep disturbance and fatigue. Most of the patients with fibromyalgia complain of either non-restorative sleep or complaints of disturbed sleep due to pain. The study aimed at examining the effects of milnacipran on sleep disturbance in patients with fibromyalgia. The study is a randomized, double-blind, placebo controlled, two way crossover polysomnography (PSG) study to explore the effects of milnacipran on sleep disturbance. Patients received either milnacipran 50 mg twice a day (BID) or matching placebo.
Primary Outcome
Number of awakenings after defined sleep onset until lights on.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Milnacipran
Study Locations (1)
Ohio
- Cleveland Sleep Research Center - Middleburg Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-02 |
| Phase | Phase 4 |
What the finished NCT01234675 record still lists
NCT01234675 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01234675 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01234675 about?
NCT01234675 is a clinical study titled "The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia". Fibromyalgia is a condition of chronic widespread pain, sleep disturbance and fatigue. Most of the patients with fibromyalgia complain of either non-restorative sleep or complaints of disturbed sleep due to pain. The study aimed at examining the effects of milnacipran on sleep disturbance in patient...
What is the current status of trial NCT01234675?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2010-11. Estimated completion is 2014-02.
What conditions does trial NCT01234675 study?
This clinical trial studies the following conditions: Sleep, Fibromyalgia, Sleep Disorders.
What interventions are being tested in trial NCT01234675?
The interventions under investigation include: Placebo (DRUG), Milnacipran (DRUG).
Who is sponsoring clinical trial NCT01234675?
This trial is sponsored by Mansoor Ahmed M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01234675 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01234675's enrollment target sits among peer trials
19 141st of 151 higher than 11 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
RECRUITING · Phase 4
-
Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial
ACTIVE NOT RECRUITING · Phase 4
-
Hypnotic Medications and Memory: Effect of Drug Exposure During the Night
COMPLETED · Phase 4
-
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
RECRUITING · Phase 1
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Research Framework Exploring Sleep Health
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia